News
- Fresenius Medical Care increased 0.4% to €27.71 after the dialysis service provider lifted its annual outlook.
Revenue in the third quarter declined 3% to €4.9 billion from €5.03 billion, net income fell to €84 million from €230 million, and net income dropped to 29 cents from 7 cents a year ago.
The company reiterated its 2023 revenue to grow at a low to mid-single-digit percentage rate from €19.4 billion in 2022.
The company raised its 2023 operating earnings to grow at a low single-digit percentage rate from €1.54 billion in 2022, from the previous outlook of flat to a decline in the low single-digit percentage rate.
The German company also said it had resolved its legal dispute with the U.S. Department of Defense and finalized its settlement for payment of dialysis services provided under the Tricare program to members of military service, their dependents, and retirees.
The company sought to receive payment for services provided under the Tricare program on or before January 11, 2023.
As a consequence of the settlement agreement, Fresenius anticipates a positive impact on operating income of €175 million in the fourth quarter.
Nov 22, 2023 - Fresenius Medical SE increased 6.9% to €27.21 after the German dialysis company reported adjusted earnings that were ahead of expectations.
Revenue in the first quarter increased 3.4% to €4.7 billion and net income fell 45.1% to €86 million from €157 million and basic earnings per share declined to 29 cents from 54 cents a year ago.
Adjusted earnings per share, which excludes the U.S. Provider Relief Funding and Ukraine war related items among other adjustments, declined to 53 cents from 67 cents a year ago.
Fresenius forecasted 2023 annual revenue "to grow at a low to mid-single digit percentage rate" from €19.39 billion and operating income to remain "flat or decline by up to a high-single digit percentage rate" from €1.54 billion.
May 9, 2023
Links
Price
- Last Close
-
$ 22.38
1.08 %
+0.24
Jan 3, 2025
- Trading Volume
- 7,284
- 52-Week High/Low
- $24 - $16
- Market Cap Full
- $ 5.7B
- YTD
- -1%
Returns +
Q
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | -1.1% | -7.4% | 30.1% | 3.8% | -11.3% | -5% | 25.1% | -2.8% | -0.2% | 5.4% | - |
| Q2 | - | 0.5% | 12.5% | -26% | 12.7% | 4% | -3.6% | 1.2% | 16% | -0.1% | - |
| Q3 | - | 0.4% | -10% | -43.7% | -15.9% | 8% | -15.8% | 2.8% | 1.2% | 0.5% | - |
| Q4 | - | -5.7% | -2.2% | 16.4% | -7.2% | -2.2% | 9.5% | -38.7% | 6.3% | -3.6% | - |
Returns +
M
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -1.1% | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | -7.4% | -0.4% | 0.4% | 6.6% | 3.5% | -9.9% | 0.6% | 0.4% | - | - | - | - |
Returns +
A
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FMS | -1% | 9% | 28% | -50% | -22% | 13% | 13% | -38% | 26% | 2% | 14% |
Earnings
| id | company_name | ticker | sector | industry | addresss | state | city | zip | country | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | ||||||||||
| Q2 | ||||||||||
| Q3 | ||||||||||
| Q4 | ||||||||||
| A |
Annual
Returns
52 Week
High/Low
Annual
Earnings
Chart
Trading Volume
Dividend +
| 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Q1 | 0.44 | 0.42 | 0.49 | 0.57 | 0.50 |
| Q2 | - | - | - | - | - |
| Q3 | - | - | - | - | - |
| Q4 | - | - | - | - | - |
| A | 0.44 | 0.42 | 0.49 | 0.57 | 0.5 |